Blue Biofuels gains Harbinger Research coverage on CTS technology commercialization path
Bitget2026/10/05 15:18Blue Biofuels (OTCQB: BIOF) gained new analyst coverage via an independent Harbinger Research report published Oct. 5, 2026. Report focuses on the company’s patented Cellulose-to-Sugar technology as it moves from pilot work toward commercial production. Coverage highlights DOE-supported scale-up, integrated demonstration plans, commercial engineering, project financing, commercial construction. Harbinger flags process efficiency, local feedstock availability, cost leadership as key factors for cellulosic ethanol, sustainable aviation fuel markets. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Blue Biofuels Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610051117PRIMZONEFULLFEED9839659) on October 05, 2026, and is solely responsible for the information contained therein.
- Blue Biofuels (OTCQB: BIOF) gained new analyst coverage via an independent Harbinger Research report published Oct. 5, 2026.
- Report focuses on the company’s patented Cellulose-to-Sugar technology as it moves from pilot work toward commercial production.
- Coverage highlights DOE-supported scale-up, integrated demonstration plans, commercial engineering, project financing, commercial construction.
- Harbinger flags process efficiency, local feedstock availability, cost leadership as key factors for cellulosic ethanol, sustainable aviation fuel markets.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Copper prices approach historic highs! UBS remains bullish: "Still most optimistic"

A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
The number of stablecoin holders on the Solana chain has surpassed 14 million.